Hanmi Pharm. Co., Ltd. (KRX:128940)

South Korea flag South Korea · Delayed Price · Currency is KRW
436,500
+22,000 (5.31%)
May 21, 2026, 3:30 PM KST
Market Cap5.26T +73.1%
Revenue (ttm)1.55T +3.5%
Net Income169.55B +39.8%
EPS13,362.00 +39.7%
Shares Out12.68M
PE Ratio31.02
Forward PE27.55
Dividend2,000.00 (0.46%)
Ex-Dividend DateMar 30, 2026
Volume90,898
Average Volume118,729
Open418,500
Previous Close414,500
Day's Range416,000 - 450,000
52-Week Range267,500 - 647,000
Beta0.43
RSI36.79
Earnings DateApr 30, 2026

About Hanmi Pharm.

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1973
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 128940
Full Company Profile

Financial Performance

In 2025, Hanmi Pharm.'s revenue was 1.55 trillion, an increase of 3.48% compared to the previous year's 1.50 trillion. Earnings were 169.55 billion, an increase of 39.76%.

Financial Statements